2025 revenue ~$2.2B, +~120% YoY (company-disclosed). Valuation has roughly doubled every year since 2022. Secondary-market price implies a materially higher current mark than the last primary round.
| Round | Date | Valuation | Lead |
|---|---|---|---|
| Series E | 2022-12-01 | $8.5B | Valor Equity Partners |
| Series F | 2024-08-01 | $14.0B+65% | Co-led by Founders Fund and Sands Capital, with new participation from Fidelity Management & Research, Counterpoint Global (Morgan Stanley), and Baillie Gifford |
| Series G | 2025-06-01 | $30.5B+118% | Founders Fund (reportedly a ~$1B check, the firm's largest single investment ever; round was ~8x oversubscribed) |
| Series H | 2026-05-13 | $61.0B+100% | Co-led by Thrive Capital and Andreessen Horowitz |
| Status | S-1 Not Filed |
|---|---|
| Timing | low single-digit years (founder's earlier estimate, undated) |
| Notes | CEO Brian Schimpf (Jul 2026): 'bad' to IPO 'in the middle of a hype cycle,' Anduril is 'not in a rush to go out.' Founder Palmer Luckey has separately said Anduril will 'definitely' go public eventually. |
| Source | CNBC, Jul 9 2026 |
These are cited news signals only, not a PrePost prediction — year/valuation forecasting is on the roadmap but not live yet.
Transparent, formula-based composite (not machine-learned) of five signals: raise velocity, round acceleration, secondary premium/discount vs. the last primary round, up-round streak, and freshness of the last known mark.